Literature DB >> 33418934

Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury.

Maria G Detsika1, Elias A Lianos2,3.   

Abstract

Heme oxygenase is a cytoprotective enzyme with strong antioxidant and anti-apoptotic properties. Its cytoprotective role is mainly attributed to its enzymatic activity, which involves the degradation of heme to biliverdin with simultaneous release of carbon monoxide (CO). Recent studies uncovered a new cytoprotective role for heme oxygenase-1 (HO-1) by identifying a regulatory role on the complement control protein decay-accelerating factor. This is a key complement regulatory protein preventing dysregulation or overactivation of complement cascades that can cause kidney injury. Cell-specific targeting of HO-1 induction may, therefore, be a novel approach to attenuate complement-dependent forms of kidney disease.

Entities:  

Keywords:  complement; heme; heme oxygenase-1 (HO-1); kidney injury

Year:  2021        PMID: 33418934      PMCID: PMC7825075          DOI: 10.3390/antiox10010060

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  119 in total

1.  Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump.

Authors:  Rui Wang; Rany Shamloul; Xiaoxia Wang; Qinghe Meng; Lingyun Wu
Journal:  Hypertension       Date:  2006-08-28       Impact factor: 10.190

2.  Heme oxygenase: protective gene or Trojan horse.

Authors:  J L Platt; K A Nath
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

3.  Glomerular proteinuria induces heme oxygenase-1 gene expression within renal epithelial cells.

Authors:  Masaki Shimizu; Kazuhide Ohta; Yonghong Yang; Akiko Nakai; Tomoko Toma; Yutaka Saikawa; Yoshihito Kasahara; Akihiro Yachie; Hitoshi Yokoyama; Hidetoshi Seki; Shoichi Koizumi
Journal:  Pediatr Res       Date:  2005-10       Impact factor: 3.756

Review 4.  Porphyria.

Authors:  D Montgomery Bissell; Karl E Anderson; Herbert L Bonkovsky
Journal:  N Engl J Med       Date:  2017-08-31       Impact factor: 91.245

5.  Evidence for glomerular modulation of complement activation.

Authors:  H L Moseley; K Whaley
Journal:  J Clin Lab Immunol       Date:  1979-04

6.  Urinary heme oxygenase-1 as a sensitive indicator of tubulointerstitial inflammatory damage in various renal diseases.

Authors:  Tadafumi Yokoyama; Masaki Shimizu; Kazuhide Ohta; Tomoji Yuno; Michiko Okajima; Taizo Wada; Tomoko Toma; Shoichi Koizumi; Akihiro Yachie
Journal:  Am J Nephrol       Date:  2011-04-18       Impact factor: 3.754

7.  Glomerular Epithelial Cells-Targeted Heme Oxygenase-1 Over Expression in the Rat: Attenuation of Proteinuria in Secondary But Not Primary Injury.

Authors:  Vassilios Atsaves; Panagiota Makri; Maria G Detsika; Alexandra Tsirogianni; Elias A Lianos
Journal:  Nephron       Date:  2016-07-22       Impact factor: 2.847

8.  Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney.

Authors:  K Abe; M Miyazaki; T Koji; A Furusu; Y Ozono; T Harada; H Sakai; P K Nakane; S Kohno
Journal:  Kidney Int       Date:  1998-07       Impact factor: 10.612

9.  Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.

Authors:  Anna Schubart; Karen Anderson; Nello Mainolfi; Holger Sellner; Takeru Ehara; Christopher M Adams; Aengus Mac Sweeney; Sha-Mei Liao; Maura Crowley; Amanda Littlewood-Evans; Sophie Sarret; Grazyna Wieczorek; Ludovic Perrot; Valérie Dubost; Thierry Flandre; Yuzhou Zhang; Richard J H Smith; Antonio M Risitano; Rajeshri G Karki; Chun Zhang; Eric Valeur; Finton Sirockin; Bernd Gerhartz; Paulus Erbel; Nicola Hughes; Thomas M Smith; Frederic Cumin; Upendra A Argikar; Börje Haraldsson; Muneto Mogi; Richard Sedrani; Christian Wiesmann; Bruce Jaffee; Jürgen Maibaum; Stefanie Flohr; Richard Harrison; Jörg Eder
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-29       Impact factor: 11.205

Review 10.  Bilirubin, a new therapeutic for kidney transplant?

Authors:  Vikram L Sundararaghavan; Sivjot Binepal; David E Stec; Puneet Sindhwani; Terry D Hinds
Journal:  Transplant Rev (Orlando)       Date:  2018-06-28       Impact factor: 3.943

View more
  1 in total

1.  Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.

Authors:  Predrag Sikiric; Anita Skrtic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Eva Lovric; Suncana Sikiric; Mario Knezevic; Sanja Strbe; Marija Milavic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.